Fennec Pharmaceuticals (FENC) Competitor Comparison
We are evaluating the key criteria listed to compare Fennec Pharmaceuticals (FENC) against its competitors in the Biotechnology industry.
Market Capitalization
214 / 368Gross Profits
123 / 278Total Revenue
177 / 300EBITDA
0 / 337Free Cashflow
106 / 352Quick Ratio
199 / 357Earnings per Share
40 / 359Dividend yield
0 / 6Total Cash
315 / 358Performance 3 years
172 / 368Performance 5 years
146 / 368Performance 10 years
175 / 368Linearity 3 years
86 / 368Linearity 5 years
25 / 368Linearity 10 years
118 / 368Total Rank
125 / 368Dividend Rank
128 / 368Valuation Rank
258 / 368Piotroski Rank
240 / 368Muliplier Rank
344 / 368Valuation Rank - FENC ranking 258 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.